Institute for Physiology, Charité - Universitätsmedizin Berlin, Germany.
Am J Respir Crit Care Med. 2012 Jan 15;185(2):160-70. doi: 10.1164/rccm.201104-0717OC.
Platelet-activating factor (PAF) increases lung vascular permeability within minutes by activation of acid sphingomyelinase (ASM) and a subsequent nitric oxide (NO)-inhibitable and Ca(2+)-dependent loss in barrier function.
To elucidate the molecular mechanisms underlying this response.
In isolated perfused rat and mouse lungs, endothelial Ca(2+) concentration (Ca(2+)) was quantified by real-time fluorescence imaging, and caveolae of endothelial cells were isolated and probed for Ca(2+) entry channels. Regulation of transient receptor potential classical (TRPC) 6-mediated currents in lung endothelial cells was assessed by patch clamp technique.
PAF increased lung weight gain and endothelial Ca(2+). This response was abrogated by inhibitors of ASM or in ASM-deficient mice, and replicated by lung perfusion with exogenous ASM or C2-ceramide. PAF increased the caveolar abundance of TRPC6 channels, which was similarly blocked by ASM inhibition. PAF-induced increases in lung endothelial Ca(2+), vascular filtration coefficient, and edema formation were attenuated by the TRPC inhibitor SKF96365 and in TRPC6-deficient mice, whereas direct activation of TRPC6 replicated the Ca(2+) and edema response to PAF. The exogenous NO donor PapaNONOate or the cyclic guanosine 3',5'-monophosphate analog 8Br-cGMP blocked the endothelial Ca(2+) and permeability response to PAF, in that they directly blocked TRPC6 channels without interfering with their PAF-induced recruitment to caveolae.
The present findings outline a new signaling cascade in the induction of PAF-induced lung edema, in that stimulation of ASM causes recruitment of TRPC6 channels to caveolae, thus allowing for Ca(2+) influx and subsequent increases in endothelial permeability that are amplified in the absence of endothelial NO synthesis.
血小板激活因子 (PAF) 通过激活酸性鞘磷脂酶 (ASM),并随后导致一氧化氮 (NO) 抑制和 Ca(2+) 依赖性屏障功能丧失,在数分钟内增加肺血管通透性。
阐明这种反应的分子机制。
在分离的灌注大鼠和小鼠肺中,通过实时荧光成像定量内皮细胞 Ca(2+) 浓度 (Ca(2+)),并分离和探测内皮细胞中的 caveolae 以探测 Ca(2+) 内流通道。通过膜片钳技术评估肺内皮细胞中瞬时受体电位经典型 (TRPC) 6 介导的电流的调节。
PAF 增加肺重量增加和内皮 Ca(2+)。ASM 抑制剂或 ASM 缺陷小鼠可阻断该反应,肺用外源性 ASM 或 C2-神经酰胺灌注可复制该反应。PAF 增加了 caveolae 中 TRPC6 通道的丰度,ASM 抑制也可类似地阻断这种增加。TRPC 抑制剂 SKF96365 和 TRPC6 缺陷小鼠可减轻 PAF 诱导的肺内皮 Ca(2+)、血管滤过系数和水肿形成的增加,而直接激活 TRPC6 可复制 PAF 引起的 Ca(2+) 和水肿反应。外源性一氧化氮供体 PapaNONOate 或环鸟苷酸 3',5'-单磷酸类似物 8Br-cGMP 阻断了内皮细胞 Ca(2+) 和对 PAF 的通透性反应,因为它们直接阻断了 TRPC6 通道,而不干扰其 PAF 诱导的募集到 caveolae。
本研究结果概述了 PAF 诱导的肺水肿诱导中的新信号级联,即刺激 ASM 导致 TRPC6 通道募集到 caveolae,从而允许 Ca(2+) 内流,随后内皮通透性增加,而内皮一氧化氮合成的缺失会放大这种增加。